Clinically Relevant Altered Antibiotic Responses and Mechanisms of β-Lactam Sensitization of MRSA in Cystic Fibrosis Artificial Sputum
ACS Infectious Diseases · 14.08.2026 · 12 (8) · 2763-2777
DOI: 10.1021/acsinfecdis.6c00319 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Infectious Diseases, online erschienen am 30.07.2026. Verfasst von Tyler J Hamelin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, Faculty of Science, University of Regina, Regina, SaskatchewanS4S 0A2, Canada. Hauptthemen laut MEDLINE: Cystic Fibrosis, Methicillin-Resistant Staphylococcus aureus, Sputum, Anti-Bacterial Agents. Die Arbeit nennt 75 Literaturangaben. Gefördert von: Canada Foundation for Innovation, Canada Foundation for Innovation and Innovation Saskatchewan grants, Canada Research Chair in Chemogenomics and Antimicrobial Research.
Abstract (Originalsprache)
Staphylococcus aureus is the most common bacterial pathogen affecting pediatric patients with cystic fibrosis (CF), a genetic disorder that causes thick mucus buildup in the lungs, providing a scaffold for chronic infections. Antibiotic treatment is typically guided by standard in vitro antimicrobial susceptibility testing (AST) in Mueller-Hinton broth (MHB), which does not represent the infection site in CF lungs. Notably, discordances between AST predictions and antibiotic therapeutic outcomes have been reported in up to 50% of CF cases. To address this gap, we conducted ASTs against methicillin-resistant S. aureus (MRSA) in CF sputum-mimetic media compared with MHB, demonstrating ≥ 4-fold discordances across four of nine antibiotic classes. Most significantly, we observed unexpected β-lactam sensitization of MRSA strains (up to 128-fold) in CF sputum-like media, crossing the clinical breakpoint, suggesting this shift may alter therapeutic outcomes. Genome-wide screens and follow-up assays revealed underlying cell envelope remodeling and alterations to cell envelope stress responses. On the other hand, mucin binding to daptomycin may have led to an apparent 8-fold increase in resistance to this antibiotic in one of the CF sputum-like media. Overall, our AST results in CF sputum-mimetic conditions provide insights into bacterial responses during CF infections. Importantly, they suggest β-lactams may be effective in treating MRSA infections in CF patients, warranting further investigation in relevant in vivo systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Biochemistry, Faculty of Science, University of Regina, Regina, SaskatchewanS4S 0A2, Canada.
ORCID-Profile: Marc R MacKinnon, Tanya E S Dahms, Omar M El-Halfawy
Förderung
- Canada Foundation for Innovation
- Canada Foundation for Innovation and Innovation Saskatchewan grants
- Canada Research Chair in Chemogenomics and Antimicrobial Research
- Cystic Fibrosis Canada Early Career Investigator Award
- Faculty of Graduate Studies and Research at the University of Regina
- Faculty of Science at the University of Regina
- Natural Science and Engineering Research Council
- Saskatchewan Health Research Foundation establishment grant
Zitieren
APA
Hamelin, T. J., Molaeitabari, A., MacKinnon, M. R., Dahms, T. E. S., & El-Halfawy, O. M. (2026). Clinically Relevant Altered Antibiotic Responses and Mechanisms of β-Lactam Sensitization of MRSA in Cystic Fibrosis Artificial Sputum. ACS Infectious Diseases, 12(8), 2763-2777. https://doi.org/10.1021/acsinfecdis.6c00319
Vancouver
Hamelin TJ, Molaeitabari A, MacKinnon MR, Dahms TES, El-Halfawy OM. Clinically Relevant Altered Antibiotic Responses and Mechanisms of β-Lactam Sensitization of MRSA in Cystic Fibrosis Artificial Sputum. ACS Infectious Diseases. 2026;12(8):2763-2777. doi:10.1021/acsinfecdis.6c00319
BibTeX
@article{Hamelin2026,
author = {Hamelin, Tyler J and Molaeitabari, Ali and MacKinnon, Marc R and Dahms, Tanya E S and El-Halfawy, Omar M},
title = {Clinically Relevant Altered Antibiotic Responses and Mechanisms of β-Lactam Sensitization of MRSA in Cystic Fibrosis Artificial Sputum},
journal = {ACS Infectious Diseases},
year = {2026},
volume = {12},
number = {8},
pages = {2763--2777},
doi = {10.1021/acsinfecdis.6c00319}
}
EUVIMED